Human Genome Sciences lupus drug met study goal

Courtesy Newsvine - business  Mon, 07/20/2009 - 11:29

Biotech drugmaker Human Genome Sciences reported positive results Monday for its experimental lupus drug, confounding analyst expectations and potentially clearing the way for the first new treatment against the inflammatory disease in a half century.


 

Related items

4As, ANA, IAB Start Cross-Media Study
Goal is to create better measurement and create common...

Higher prices help Hormel 1Q net rise 34 percent
Hormel Foods Corp.'s first-quarter net income jumped 34 percent on stronger sales and higher prices, and the company raised its full-year outlook.The maker of products including Spam and...

Target Dec. revenue figure rises nearly 1 percent
Target Corp. says a key revenue figure edged up 0.9 percent in December but fell well short of analyst expectations. Its shares tumbled 5 percent in pre-market trading.

Samsung SCX-4200 3-in-1 True Multifunction Printer
The SCX-4200 Digital Productivity Center is a low cost black and white laser printer, delivering 3 in 1 true multifunction performance with professional laser output.Keep your valuable real...

BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com